<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="658">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05152589</url>
  </required_header>
  <id_info>
    <org_study_id>E2-21-1070</org_study_id>
    <nct_id>NCT05152589</nct_id>
  </id_info>
  <brief_title>Maternal Diabetes in Newborns With Hearing Loss</brief_title>
  <acronym>GDM</acronym>
  <official_title>Newborn Hearing Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the presence and characteristics of maternal diabetes as a&#xD;
      risk factor in newborns with hearing loss.&#xD;
&#xD;
      Hearing loss is one of the most common congenital anomalies among newborns. The newborn&#xD;
      hearing screening program is important for early diagnosis in newborns with hearing&#xD;
      loss.Gestational diabetes, on the other hand, is a metabolic disease that occurs during&#xD;
      pregnancy and can cause complications as in other diabetes mellitus patients.&#xD;
&#xD;
      Despite our knowledge of major complications, the effect of the hyperglycemic intrauterine&#xD;
      environment on hearing outcomes has not been adequately studied. The inner ear does not store&#xD;
      energy, so it has a particularly high sensitivity to altered blood sugar and insulin. Altered&#xD;
      inner ear metabolism leads to auditory and balance disorders.&#xD;
&#xD;
      There is no study in the literature comparing uncomplicated gestational diabetes and&#xD;
      pregestational diabetes as a prenatal complication that poses a risk of hearing loss.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Hearing Loss</measure>
    <time_frame>6 months</time_frame>
    <description>Hearing test results in babies with no diabetes, pregestational diabetes, and gestational diabetes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diabetic mother</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of classification tests by separating them from subgroups according to mothers' control times, usage controls, and glycemic viewers</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Pregestational Diabetes</condition>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>gestational diabetic mother</arm_group_label>
    <description>Hearing tests of the babies of pregnant women who are being followed up with the diagnosis of gestational diabetes in the peritanotogy clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregestational diabetic mother</arm_group_label>
    <description>Hearing tests of the babies of pregnant women who are being followed up with the diagnosis of pregestational diabetes in the peritanotogy clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non diabetic mother</arm_group_label>
    <description>Hearing tests of babies whose mothers do not have gestational or pregestational diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>hearing test</intervention_name>
    <description>Auditory Brainstem Response (ABR) Test</description>
    <arm_group_label>gestational diabetic mother</arm_group_label>
    <arm_group_label>non diabetic mother</arm_group_label>
    <arm_group_label>pregestational diabetic mother</arm_group_label>
    <other_name>ABR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        NEWBORNS WHO CANNOT PASS THE HEARING TEST APPLIED AS ROUTINE SCREENING&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  POSTNATAL AGE BETWEEN 0-28 DAYS&#xD;
&#xD;
          -  BIRTH WEIGHT â‰¥2000GR&#xD;
&#xD;
          -  TO HAVE TESTED ON THE NEWBORN HEARING SCREENING UNIT AT ANKARA CITY HOSPITAL&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PRETERMS&#xD;
&#xD;
          -  CRANIOFACIAL ANOMALIES&#xD;
&#xD;
          -  INTRAUTERINE INFECTIONS&#xD;
&#xD;
          -  BIRTH WEIGHT &lt;2000 GR&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fuat Emre Canpolat</name>
      <address>
        <city>Ankara</city>
        <state>[Select]</state>
        <zip>06800</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 29, 2021</study_first_submitted>
  <study_first_submitted_qc>November 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>November 29, 2021</last_update_submitted>
  <last_update_submitted_qc>November 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

